Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
30.90
-0.05 (-0.16%)
Jan 22, 2026, 1:00 PM CST
Sinphar Pharmaceutical Revenue
Sinphar Pharmaceutical had revenue of 872.73M TWD in the quarter ending September 30, 2025, with 16.44% growth. This brings the company's revenue in the last twelve months to 3.35B, up 9.88% year-over-year. In the year 2024, Sinphar Pharmaceutical had annual revenue of 3.15B with 6.33% growth.
Revenue (ttm)
3.35B
Revenue Growth
+9.88%
P/S Ratio
1.76
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.15B | 187.69M | 6.33% |
| Dec 31, 2023 | 2.96B | 106.28M | 3.72% |
| Dec 31, 2022 | 2.86B | 423.14M | 17.39% |
| Dec 31, 2021 | 2.43B | 45.06M | 1.89% |
| Dec 31, 2020 | 2.39B | -6.14M | -0.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |